Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000009

CFO AND TREASURER sold 10,000 shares at an average $574.88 ($5,748,802)

  • CFO AND TREASURER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-13 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $135.42 $1,354,200 28,876 D
2026-04-13 Sale : show line 2 in the form 10b5-1 −40 $569.61 $22,784 28,836 D
2026-04-13 Sale : show line 3 in the form 10b5-1 −281 $571.14 $160,490 28,555 D
2026-04-13 Sale : show line 4 in the form 10b5-1 −1,154 $571.76 $659,814 27,401 D
2026-04-13 Sale : show line 5 in the form 10b5-1 −1,210 $572.96 $693,279 26,191 D
2026-04-13 Sale : show line 6 in the form 10b5-1 −1,860 $574.00 $1,067,636 24,331 D
2026-04-13 Sale : show line 7 in the form 10b5-1 −1,457 $575.06 $837,856 22,874 D
2026-04-13 Sale : show line 8 in the form 10b5-1 −1,354 $575.96 $779,844 21,520 D
Open-market sales · 10,000 sh · avg $574.88 · $5,748,802

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-13 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −10,000 92,500 D
Loading xslF345X06/primarydocument.xml…